La Jolla Pharmaceutical Company - Financial and Strategic Analysis Review

Summary

La Jolla Pharmaceutical Company - Financial and Strategic Analysis Review

La Jolla Pharmaceutical Company (La Jolla) is a biopharmaceutical Company primarily involved in developing pharmaceutical products to treat patients with lupus. The company's lead product in development is Riquent, which is in Phase 3 ASPEN clinical trials to treat patients with lupus. The Lupus is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues. The company also discovers and develops orally-active small molecules for the treatment of autoimmune diseases, and acute and chronic inflammatory disorders. The company has its operation principally in the US. The company is headquartered in San Diego, California

Global Markets Direct's La Jolla Pharmaceutical Company - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of La Jolla Pharmaceutical Company. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • Key Facts
  • Business Description
  • Major Products and Services
  • History
  • SWOT Analysis
  • SWOT Analysis - Overview
  • La Jolla Pharmaceutical Company - Strengths
  • La Jolla Pharmaceutical Company - Strengths - Tolerance Technology
  • La Jolla Pharmaceutical Company - Strengths - Focused Research and Development Activities
  • La Jolla Pharmaceutical Company - Strengths - Strong Patent Portfolio
  • La Jolla Pharmaceutical Company - Weaknesses
  • La Jolla Pharmaceutical Company - Weaknesses - Lack of Marketed Products
  • La Jolla Pharmaceutical Company - Weaknesses - Failure of Clinical Trials for Riquent
  • La Jolla Pharmaceutical Company - Opportunities
  • La Jolla Pharmaceutical Company - Opportunities - Emerging Markets
  • La Jolla Pharmaceutical Company - Opportunities - Changing Demographics
  • La Jolla Pharmaceutical Company - Threats
  • La Jolla Pharmaceutical Company - Threats - Competition
  • La Jolla Pharmaceutical Company - Threats - Tightening of FDA's Regulatory Oversight
  • La Jolla Pharmaceutical Company - Threats - Industry Consolidation
  • La Jolla Pharmaceutical Company - Threats - Impact of Financial Crisis
  • Key Competitors
  • Key Employees
  • Key Employee Biographies
  • Locations And Subsidiaries
  • Locations And Subsidiaries - Head Office
  • Locations And Subsidiaries - Other Locations & Subsidiaries
  • Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • La Jolla Pharmaceutical Company, Key Facts
  • Major Products and Services
  • La Jolla Pharmaceutical Company, History
  • La Jolla Pharmaceutical Company, Key Employees
  • La Jolla Pharmaceutical Company, Key Employee Biographies
  • La Jolla Pharmaceutical Company, Subsidiaries
  • La Jolla Pharmaceutical Company, Ratios based on current share price
  • La Jolla Pharmaceutical Company, Annual Ratios
  • La Jolla Pharmaceutical Company, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • La Jolla Pharmaceutical Company, Ratio Charts